Article
The hedgehog pathway in triple‐negative breast cancer
18 Aug 2016
Abstract excerpt
Treatment of triple-negative breast cancer (TNBC) remains challenging due to the underlying heterogeneity of this disease coupled with the lack of predictive biomarkers and effective targeted therapies. Intratumoral heterogeneity, particularly enrichment for breast cancer stem cell-like subpopulations, has emerged as a leading hypothesis for systemic therapy resistance and clinically aggressive course of poor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
